OBJECTIVE: Long pentraxin PTX3 is an inflammatory mediator and a component of the humoral arm of innate immunity. PTX3 expression is increased in animals with acute lung injury (ALI) and in patients with sepsis or acute respiratory distress syndrome and is considered to be a potential biomarker for these diseases. However, the role of PTX3 in the pathogenesis of ALI is not fully understood. We hypothesized that PTX3, as an important immune modulator, may determine the severity of ALI. METHODS: Lipopolysaccharide (LPS) was intra-tracheally administrated to PTX3 knock-out (PTX3-KO) and wild-type (WT) mice. Lung injury, neutrophil infiltration, cell death, fibrin deposition, and tissue factor expression in the lung were determined. Local and systemic inflammatory responses were assessed by measuring cytokines in the lung and plasma. RESULTS: LPS instillation induced ALI in both PTX3-KO and WT mice. Interestingly, PTX3 deficiency significantly increased the magnitude/extent of lung injury compared to that in WT mice. The severe lung injury was accompanied by elevated neutrophil infiltration, cell death, and fibrin deposition in the lung. PTX3 deficiency also enhanced LPS-induced tissue factor expression/activation in the lung and increased tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels in the plasma. CONCLUSION: Our data suggest that the endogenously expressed PTX3 plays a protective role in the pathogenesis of ALI and that a lack of PTX3 may enhance neutrophil recruitment, cell death, activation of coagulation cascades, and inflammatory responses in the lung.
OBJECTIVE: Long pentraxin PTX3 is an inflammatory mediator and a component of the humoral arm of innate immunity. PTX3 expression is increased in animals with acute lung injury (ALI) and in patients with sepsis or acute respiratory distress syndrome and is considered to be a potential biomarker for these diseases. However, the role of PTX3 in the pathogenesis of ALI is not fully understood. We hypothesized that PTX3, as an important immune modulator, may determine the severity of ALI. METHODS:Lipopolysaccharide (LPS) was intra-tracheally administrated to PTX3 knock-out (PTX3-KO) and wild-type (WT) mice. Lung injury, neutrophil infiltration, cell death, fibrin deposition, and tissue factor expression in the lung were determined. Local and systemic inflammatory responses were assessed by measuring cytokines in the lung and plasma. RESULTS:LPS instillation induced ALI in both PTX3-KO and WT mice. Interestingly, PTX3 deficiency significantly increased the magnitude/extent of lung injury compared to that in WT mice. The severe lung injury was accompanied by elevated neutrophil infiltration, cell death, and fibrin deposition in the lung. PTX3 deficiency also enhanced LPS-induced tissue factor expression/activation in the lung and increased tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels in the plasma. CONCLUSION: Our data suggest that the endogenously expressed PTX3 plays a protective role in the pathogenesis of ALI and that a lack of PTX3 may enhance neutrophil recruitment, cell death, activation of coagulation cascades, and inflammatory responses in the lung.
Authors: Bing Han; Marco Mura; Cristiano F Andrade; Daisuke Okutani; Monika Lodyga; Claudia C dos Santos; Shaf Keshavjee; Michael Matthay; Mingyao Liu Journal: J Immunol Date: 2005-12-15 Impact factor: 5.422
Authors: Silvia Bozza; Francesco Bistoni; Roberta Gaziano; Lucia Pitzurra; Teresa Zelante; Pierluigi Bonifazi; Katia Perruccio; Silvia Bellocchio; Mariella Neri; Anna Maria Iorio; Giovanni Salvatori; Rita De Santis; Mario Calvitti; Andrea Doni; Cecilia Garlanda; Alberto Mantovani; Luigina Romani Journal: Blood Date: 2006-07-13 Impact factor: 22.113
Authors: Marco Mura; Matthew Binnie; Bing Han; Chengjin Li; Cristiano F Andrade; Atsushi Shiozaki; Yu Zhang; Napoleone Ferrara; David Hwang; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu Journal: Am J Pathol Date: 2010-02-18 Impact factor: 4.307
Authors: Emanuela Napoleone; Angelomaria di Santo; Giuseppe Peri; Alberto Mantovani; Giovanni de Gaetano; Maria Benedetta Donati; Roberto Lorenzet Journal: J Leukoc Biol Date: 2004-07 Impact factor: 4.962
Authors: Marco Mura; Bing Han; Cristiano F Andrade; Rashmi Seth; David Hwang; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: J M Diamond; D J Lederer; S M Kawut; J Lee; V N Ahya; S Bellamy; S M Palmer; V N Lama; S Bhorade; M Crespo; E Demissie; J Sonett; K Wille; J Orens; P D Shah; A Weinacker; D Weill; B A Kohl; C C Deutschman; S Arcasoy; A S Shah; J A Belperio; D Wilkes; J M Reynolds; L B Ware; J D Christie Journal: Am J Transplant Date: 2011-08-22 Impact factor: 8.086
Authors: Luis Perea; Mar Coll; Lucia Sanjurjo; Delia Blaya; Adil El Taghdouini; Daniel Rodrigo-Torres; José Altamirano; Isabel Graupera; Beatriz Aguilar-Bravo; Marta Llopis; Julia Vallverdú; Joan Caballeria; Leo A van Grunsven; Maria-Rosa Sarrias; Pere Ginès; Pau Sancho-Bru Journal: Hepatology Date: 2017-07-18 Impact factor: 17.425
Authors: Joshua M Diamond; Nuala J Meyer; Rui Feng; Melanie Rushefski; David J Lederer; Steven M Kawut; James C Lee; Edward Cantu; Rupal J Shah; Vibha N Lama; Sangeeta Bhorade; Maria Crespo; Ejigayehu Demissie; Joshua Sonett; Keith Wille; Jonathan Orens; Ann Weinacker; David Weill; Selim Arcasoy; Pali D Shah; John A Belperio; David Wilkes; Lorraine B Ware; Scott M Palmer; Jason D Christie Journal: Am J Respir Crit Care Med Date: 2012-07-19 Impact factor: 21.405
Authors: Akihiro Shindo; Takakuni Maki; Emiri T Mandeville; Anna C Liang; Naohiro Egawa; Kanako Itoh; Naoki Itoh; Mia Borlongan; Julie C Holder; Tsu Tshen Chuang; John D McNeish; Hidekazu Tomimoto; Josephine Lok; Eng H Lo; Ken Arai Journal: Stroke Date: 2016-03-10 Impact factor: 7.914
Authors: A Landsem; H Fure; D Christiansen; E W Nielsen; B Østerud; T E Mollnes; O L Brekke Journal: Clin Exp Immunol Date: 2015-08-02 Impact factor: 4.330